Delivery Order SPE2DB24D8003-SPE2DB25FJTUK
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, with ID SPE2DB24D8002|SPE2DB25FJMXS, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm-fixed-price delivery order is for the supply of LOSARTAN-HCTZ 100-25 MG TAB 90S, a pharmaceutical product. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's ECAT Generation V...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide DIOVAN HCT 160-25 MG TABLET 90S. The contract, valued at $3,570.23, has an ultimate completion date of October 24, 2024 and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to deliver a comprehensive range...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product Losartan-HCTZ 100-25 mg tablets, with a ceiling value of $2,005.84 and a period of performance through March 12, 2024. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award, valued at $8,187.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $1,218.75 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with an ultimate completion date of June 26, 2024. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of Losartan Potassium 50 mg tablets, a cardiovascular medication, with a ceiling value of $1,186.90 and a completion date of July 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,415.25 fixed-price delivery order is for 4,566,949,578 units of Losartan Potassium 50 mg tablets. The IDC, valued at $999,999,999, is a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,333.47, is for the delivery of losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,754.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,373,891 units of Losartan Potassium 25mg tablets. The contract has an ultimate completion date of November 8, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...